Advertisement

Bleeding Disorders in Adolescents

      Adolescents who have bleeding disorders are more likely to experience abnormal reproductive tract bleeding, particularly menorrhagia or heavy menstrual bleeding. Even though most abnormal reproductive tract bleeding in adolescents is not attributable to a bleeding disorder, adolescents with abnormal reproductive tract bleeding are more likely to have an underlying bleeding disorder. After proper evaluation, most abnormal reproductive tract bleeding in adolescents can be managed hormonally, with the addition of hemostatic therapies when necessary.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Nichols W.
        • Hultin M.
        • James A.
        • et al.
        The diagnosis, evaluation and management of von Willebrand disease.
        National Heart Lung and Blood Institute, National Institutes of Health, Bethesda (MD)2007
        • Roberts H.
        • Escobar M.
        Other clotting factor deficiencies.
        in: Hoffman R. Hematology: basic principles and practice. 4th edition. Churchill Livingstone, New York2005
        • James A.H.
        More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders.
        Haemophilia. 2005; 11: 295-307
        • Kirtava A.
        • Drews C.
        • Lally C.
        • et al.
        Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study.
        Haemophilia. 2003; 9: 292-297
        • Sramek A.
        • Eikenboom J.C.
        • Briet E.
        • et al.
        Usefulness of patient interview in bleeding disorders.
        Arch Intern Med. 1995; 155: 1409-1415
        • Lopez J.A.
        • Andrews R.K.
        • Afshar-Kharghan V.
        • et al.
        Bernard-Soulier syndrome.
        Blood. 1998; 91: 4397-4418
        • George J.N.
        • Caen J.P.
        • Nurden A.T.
        Glanzmann's thrombasthenia: the spectrum of clinical disease.
        Blood. 1990; 75: 1383-1395
        • Kadir R.A.
        • Economides D.L.
        • Lee C.A.
        Factor XI deficiency in women.
        Am J Hematol. 1999; 60: 48-54
        • Kadir R.A.
        • Economides D.L.
        • Sabin C.A.
        • et al.
        Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders.
        Haemophilia. 1999; 5: 40-48
        • Mauser Bunschoten E.P.
        • van Houwelingen J.C.
        • Sjamsoedin Visser E.J.
        • et al.
        Bleeding symptoms in carriers of hemophilia A and B.
        Thromb Haemost. 1988; 59: 349-352
        • Greer I.A.
        • Lowe G.D.
        • Walker J.J.
        • et al.
        Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies.
        Br J Obstet Gynaecol. 1991; 98: 909-918
        • Yang J.
        • Hartmann K.E.
        • Savitz D.A.
        • et al.
        Vaginal bleeding during pregnancy and preterm birth.
        Am J Epidemiol. 2004; 160: 118-125
        • Burrows R.F.
        • Ray J.G.
        • Burrows E.A.
        Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature.
        Obstet Gynecol Surv. 2000; 55: 103-108
        • Lak M.
        • Keihani M.
        • Elahi F.
        • et al.
        Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia.
        Br J Haematol. 1999; 107: 204-206
        • Lak M.
        • Peyvandi F.
        • Ali Sharifian A.
        • et al.
        Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency.
        J Thromb Haemost. 2003; 1: 1852-1853
        • Shetty S.
        • Madkaikar M.
        • Nair S.
        • et al.
        Combined factor V and VIII deficiency in Indian population.
        Haemophilia. 2000; 6: 504-507
        • James A.
        • Matchar D.B.
        • Myers E.R.
        Testing for von Willebrand disease in women with menorrhagia: a systematic review.
        Obstet Gynecol. 2004; 104: 381-388
        • Philipp C.S.
        • Faiz A.
        • Dowling N.
        • et al.
        Age and the prevalence of bleeding disorders in women with menorrhagia.
        Obstet Gynecol. 2005; 105: 61-66
        • ACOG
        Menstruation in girls and adolescents: using the menstrual cycle as a vital sign.
        American College of Obstetricians and Gynecologists, Washington, DC2006
        • ACOG
        Management of anovulatory bleeding.
        American College of Obstetricians and Gynecologists, Washington, DC2000
        • Hallberg L.
        • Hogdahl A.M.
        • Nilsson L.
        • et al.
        Menstrual blood loss—a population study. Variation at different ages and attempts to define normality.
        Acta Obstet Gynecol Scand. 1966; 45: 320-351
        • Hallberg L.
        • Hogdahl A.M.
        • Nilsson L.
        • et al.
        Menstrual blood loss and iron deficiency.
        Acta Med Scand. 1966; 180: 639-650
        • Warner P.E.
        • Critchley H.O.
        • Lumsden M.A.
        • et al.
        Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia?.
        Am J Obstet Gynecol. 2004; 190: 1224-1229
        • Higham J.M.
        • O'Brien P.M.
        • Shaw R.W.
        Assessment of menstrual blood loss using a pictorial chart.
        Br J Obstet Gynaecol. 1990; 97: 734-739
        • Janssen C.A.
        • Scholten P.C.
        • Heintz A.P.
        A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.
        Obstet Gynecol. 1995; 85: 977-982
        • Reid P.C.
        • Coker A.
        • Coltart R.
        Assessment of menstrual blood loss using a pictorial chart: a validation study.
        BJOG. 2000; 107: 320-322
        • Warner P.E.
        • Critchley H.O.
        • Lumsden M.A.
        • et al.
        Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data.
        Am J Obstet Gynecol. 2004; 190: 1216-1223
        • Philipp C.S.
        • Faiz A.
        • Dowling N.F.
        • et al.
        Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation.
        Am J Obstet Gynecol. 2008; 198 (e161–8): 163
        • Silwer J.
        von Willebrand's disease in Sweden.
        Acta Paediatr Scand Suppl. 1973; 238: 1-159
        • Gomez A.
        • Lucia J.F.
        • Perella M.
        • et al.
        Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease.
        Haemophilia. 1998; 4: 60-62
        • Jarvis R.R.
        • Olsen M.E.
        Type I von Willebrand's disease presenting as recurrent corpus hemorrhagicum.
        Obstet Gynecol. 2002; 99: 887-888
        • Ghosh K.
        • Mohanty D.
        • Pathare A.V.
        • et al.
        Recurrent haemoperitoneum in a female patient with type III von Willebrand's disease responded to administration of oral contraceptive.
        Haemophilia. 1998; 4: 767-768
        • Bottini E.
        • Pareti F.I.
        • Mari D.
        • et al.
        Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports.
        Haematologica. 1991; 76: 431-433
        • Lobo R.A.
        Endometriosis: etiology, pathology, diagnosis, management.
        in: Katz V. Lentz G. Lobo R. Katz: comprehensive gynecology. 5th edition. Mosby, Philadelphia2007: 473-495
        • Vercellini P.
        • De Giorgi O.
        • Aimi G.
        • et al.
        Menstrual characteristics in women with and without endometriosis.
        Obstet Gynecol. 1997; 90: 264-268
        • Foster P.A.
        The reproductive health of women with von Willebrand disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
        Thromb Haemost. 1995; 74: 784-790
        • Beller F.K.
        • Ebert C.
        Effects of oral contraceptives on blood coagulation. A review.
        Obstet Gynecol Surv. 1985; 40: 425-436
        • Kadir R.A.
        • Economides D.L.
        • Sabin C.A.
        • et al.
        Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive.
        Thromb Haemost. 1999; 82: 1456-1461
        • Middeldorp S.
        • Meijers J.C.
        • van den Ende A.E.
        • et al.
        Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
        Thromb Haemost. 2000; 84: 4-8
        • Kingman C.E.
        • Kadir R.A.
        • Lee C.A.
        • et al.
        The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders.
        BJOG. 2004; 111: 1425-1428
        • Edelman A.B.
        • Koontz S.L.
        • Nichols M.D.
        • et al.
        Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?.
        Obstet Gynecol. 2006; 107: 657-665
        • Amesse L.S.
        • Pfaff-Amesse T.
        • Leonardi R.
        • et al.
        Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study.
        J Pediatr Hematol Oncol. 2005; 27: 357-363
      1. Kouides PA, Heit JA, Philipp CS, et al. A multi-site, prospective, cross-over study of intranasal desmopressin and oral tranexamic acid in women with menorrhagia and abnormal laboratory hemostasis. Blood 2007;110:711 [ASH Annual Meeting Abstracts].

        • Ozelo M.C.
        • Svirin P.
        • Larina L.
        Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
        Ann Hematol. 2005; 84: 816-822
        • Levens E.D.
        • Scheinberg P.
        • DeCherney A.H.
        Severe menorrhagia associated with thrombocytopenia.
        Obstet Gynecol. 2007; 110: 913-917
        • DeVore G.R.
        • Owens O.
        • Kase N.
        Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding—a double-blind randomized control study.
        Obstet Gynecol. 1982; 59: 285-291
        • Livio M.
        • Mannucci P.M.
        • Vigano G.
        • et al.
        Conjugated estrogens for the management of bleeding associated with renal failure.
        N Engl J Med. 1986; 315: 731-735
        • Lobo R.A.
        Abnormal uterine bleeding.
        in: Katz V. Lentz G. Lobo R. Katz: comprehensive gynecology. 5th edition. Mosby, Philadelphia2007: 915-929
        • Laufer M.R.
        • Townsend N.L.
        • Parsons K.E.
        • et al.
        Inducing amenorrhea during bone marrow transplantation. A pilot study of leuprolide acetate.
        J Reprod Med. 1997; 42: 537-541
        • Amsterdam A.
        • Jakubowski A.
        • Castro-Malaspina H.
        • et al.
        Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation.
        Bone Marrow Transplant. 2004; 34: 363-366
        • Rouhani G.
        • Menon S.
        • Burgis J.
        • et al.
        An unusual method to manage a rare blood dyscrasia.
        J Pediatr Adolesc Gynecol. 2003; 20: S123-S124
        • Bowkley C.W.
        • Dubel G.J.
        • Haas R.A.
        • et al.
        Uterine artery embolization for control of life-threatening hemorrhage at menarche: brief report.
        J Vasc Interv Radiol. 2007; 18: 127-131
        • Markovitch O.
        • Ellis M.
        • Holzinger M.
        • et al.
        Severe juvenile vaginal bleeding due to Glanzmann's thrombasthenia: case report and review of the literature.
        Am J Hematol. 1998; 57: 225-227
        • Claessens E.A.
        • Cowell C.A.
        Acute adolescent menorrhagia.
        Am J Obstet Gynecol. 1981; 139: 277-280
        • Smith Y.R.
        • Quint E.H.
        • Hertzberg R.B.
        Menorrhagia in adolescents requiring hospitalization.
        J Pediatr Adolesc Gynecol. 1998; 11: 13-15
        • Oral E.
        • Cagdas A.
        • Gezer A.
        • et al.
        Hematological abnormalities in adolescent menorrhagia.
        Arch Gynecol Obstet. 2002; 266: 72-74
        • Bevan J.A.
        • Maloney K.W.
        • Hillery C.A.
        • et al.
        Bleeding disorders: a common cause of menorrhagia in adolescents.
        J Pediatr. 2001; 138: 856-861
        • Jayasinghe Y.
        • Moore P.
        • Donath S.
        • et al.
        Bleeding disorders in teenagers presenting with menorrhagia.
        Aust N Z J Obstet Gynaecol. 2005; 45: 439-443
        • Mikhail S.
        • Varadarajan R.
        • Kouides P.
        The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre.
        Haemophilia. 2007; 13: 627-632